Displaying 13 - 21 of 21
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
Cirrhosis & Complications
1

Sobi: When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD) - ILC 2021

View
Displaying 13 - 21 of 21